Atrinsic, Inc. Stock Other OTC
Equities
US04964C2089
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 4.39M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 7.63M | Net cash position 2023 | 4.06M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.94
x | P/E ratio 2023 |
-0.86
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.17% |
Managers | Title | Age | Since |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 16-01-31 |
Andrew Slee
COO | Chief Operating Officer | 74 | 16-01-31 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 16-02-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 94-02-02 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 16-02-11 |
Brian Corvese
BRD | Director/Board Member | 67 | 17-07-27 |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |